S&P 500   4,603.96 (+-0.01%)
DOW   36,272.44 (+0.07%)
QQQ   393.25 (+0.28%)
AAPL   192.73 (-1.52%)
MSFT   368.01 (-1.66%)
META   324.59 (-2.45%)
GOOGL   132.70 (-1.70%)
AMZN   144.86 (-1.74%)
TSLA   241.80 (-0.84%)
NVDA   467.71 (-1.55%)
NIO   7.47 (+1.22%)
BABA   70.93 (-1.68%)
AMD   131.66 (+2.13%)
T   16.64 (-1.65%)
F   11.05 (+0.36%)
MU   77.34 (+3.18%)
CGC   0.77 (-3.76%)
GE   120.00 (-0.49%)
DIS   92.63 (-0.20%)
AMC   6.79 (-2.02%)
PFE   28.54 (-0.83%)
PYPL   59.40 (+0.78%)
XOM   99.03 (-0.52%)
S&P 500   4,603.96 (+-0.01%)
DOW   36,272.44 (+0.07%)
QQQ   393.25 (+0.28%)
AAPL   192.73 (-1.52%)
MSFT   368.01 (-1.66%)
META   324.59 (-2.45%)
GOOGL   132.70 (-1.70%)
AMZN   144.86 (-1.74%)
TSLA   241.80 (-0.84%)
NVDA   467.71 (-1.55%)
NIO   7.47 (+1.22%)
BABA   70.93 (-1.68%)
AMD   131.66 (+2.13%)
T   16.64 (-1.65%)
F   11.05 (+0.36%)
MU   77.34 (+3.18%)
CGC   0.77 (-3.76%)
GE   120.00 (-0.49%)
DIS   92.63 (-0.20%)
AMC   6.79 (-2.02%)
PFE   28.54 (-0.83%)
PYPL   59.40 (+0.78%)
XOM   99.03 (-0.52%)
S&P 500   4,603.96 (+-0.01%)
DOW   36,272.44 (+0.07%)
QQQ   393.25 (+0.28%)
AAPL   192.73 (-1.52%)
MSFT   368.01 (-1.66%)
META   324.59 (-2.45%)
GOOGL   132.70 (-1.70%)
AMZN   144.86 (-1.74%)
TSLA   241.80 (-0.84%)
NVDA   467.71 (-1.55%)
NIO   7.47 (+1.22%)
BABA   70.93 (-1.68%)
AMD   131.66 (+2.13%)
T   16.64 (-1.65%)
F   11.05 (+0.36%)
MU   77.34 (+3.18%)
CGC   0.77 (-3.76%)
GE   120.00 (-0.49%)
DIS   92.63 (-0.20%)
AMC   6.79 (-2.02%)
PFE   28.54 (-0.83%)
PYPL   59.40 (+0.78%)
XOM   99.03 (-0.52%)
S&P 500   4,603.96 (+-0.01%)
DOW   36,272.44 (+0.07%)
QQQ   393.25 (+0.28%)
AAPL   192.73 (-1.52%)
MSFT   368.01 (-1.66%)
META   324.59 (-2.45%)
GOOGL   132.70 (-1.70%)
AMZN   144.86 (-1.74%)
TSLA   241.80 (-0.84%)
NVDA   467.71 (-1.55%)
NIO   7.47 (+1.22%)
BABA   70.93 (-1.68%)
AMD   131.66 (+2.13%)
T   16.64 (-1.65%)
F   11.05 (+0.36%)
MU   77.34 (+3.18%)
CGC   0.77 (-3.76%)
GE   120.00 (-0.49%)
DIS   92.63 (-0.20%)
AMC   6.79 (-2.02%)
PFE   28.54 (-0.83%)
PYPL   59.40 (+0.78%)
XOM   99.03 (-0.52%)

PMV Pharmaceuticals (PMVP) News Today

$2.25
-0.06 (-2.60%)
(As of 09:51 AM ET)
Compare
Today's Range
$2.24
▼
$2.31
50-Day Range
$1.23
▼
$6.60
52-Week Range
$1.17
▼
$10.22
Volume
10,301 shs
Average Volume
572,043 shs
Market Capitalization
$115.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
seekingalpha.com logoPMV Pharmaceuticals: In A Stronger Position Now Than Before, At A Lower Price
seekingalpha.com - November 14 at 7:37 PM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Century Therapeutics (IPSC), Phathom Pharmaceuticals (PHAT)
markets.businessinsider.com - November 10 at 10:01 PM
finanznachrichten.de logoPMV Pharmaceuticals, Inc.: PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights
finanznachrichten.de - November 9 at 3:59 PM
finance.yahoo.com logoPMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights
finance.yahoo.com - November 9 at 10:46 AM
finance.yahoo.com logoPMV Pharmaceuticals Inc (PMVP) Reports Q3 2023 Financial Results and Corporate Updates
finance.yahoo.com - November 9 at 10:46 AM
markets.businessinsider.com logoPMV Pharmaceuticals Receives ‘Buy’ Rating Based on PYNNACLE Trial Results and Ongoing Cancer Research Progress
markets.businessinsider.com - October 16 at 2:25 PM
finance.yahoo.com logoPMV Pharmaceuticals, Inc. (PMVP) Loses -70.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
finance.yahoo.com - October 16 at 2:25 PM
msn.com logoPrecision Oncology PMV Pharmaceuticals Reveals Early Data From Cancer Study In Pretreated Patients
msn.com - October 12 at 7:31 PM
finance.yahoo.com logoPMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation
finance.yahoo.com - October 12 at 2:30 PM
marketbeat.com logo
marketbeat.com - October 12 at 12:35 PM
finance.yahoo.com logoPMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar
finance.yahoo.com - October 11 at 1:59 PM
finance.yahoo.com logoWall Street Analysts See a 239.26% Upside in PMV Pharmaceuticals, Inc. (PMVP): Can the Stock Really Move This High?
finance.yahoo.com - October 6 at 3:41 PM
marketbeat.com logo30,500 Shares in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Acquired by Denali Advisors LLC
marketbeat.com - September 29 at 6:43 AM
finance.yahoo.com logoPMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
finance.yahoo.com - September 20 at 6:46 PM
marketbeat.com logoPMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Purchased by Principal Financial Group Inc.
marketbeat.com - September 3 at 4:26 AM
finance.yahoo.com logoWall Street Analysts Think PMV Pharmaceuticals, Inc. (PMVP) Could Surge 182.64%: Read This Before Placing a Bet
finance.yahoo.com - August 30 at 4:28 PM
finance.yahoo.com logoPMV Pharmaceuticals, Inc. (PMVP)'s Technical Outlook is Bright After Key Golden Cross
finance.yahoo.com - August 29 at 6:21 PM
marketbeat.com logoPMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Sees Large Drop in Short Interest
marketbeat.com - August 28 at 3:22 AM
marketbeat.com logoPMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Bought by Connor Clark & Lunn Investment Management Ltd.
marketbeat.com - August 25 at 5:19 AM
marketbeat.com logo33,272 Shares in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Purchased by Y Intercept Hong Kong Ltd
marketbeat.com - August 21 at 4:52 AM
marketbeat.com logoEquities Analysts Set Expectations for PMV Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:PMVP)
marketbeat.com - August 14 at 4:59 AM
msn.com logoHC Wainwright & Co. Maintains PMV Pharmaceuticals (PMVP) Buy Recommendation
msn.com - August 11 at 6:32 PM
marketbeat.com logoHC Wainwright Cuts PMV Pharmaceuticals (NASDAQ:PMVP) Price Target to $29.00
marketbeat.com - August 11 at 7:59 AM
finanznachrichten.de logoPMV Pharmaceuticals, Inc.: PMV Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Highlights
finanznachrichten.de - August 9 at 1:04 PM
finance.yahoo.com logoPMV Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Highlights
finance.yahoo.com - August 9 at 1:04 PM
marketbeat.com logoVontobel Holding Ltd. Makes New Investment in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
marketbeat.com - June 29 at 4:26 AM
finance.yahoo.com logoPMVP Jul 2023 5.000 call
finance.yahoo.com - June 20 at 6:27 PM
marketbeat.com logoVerition Fund Management LLC Boosts Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
marketbeat.com - June 13 at 5:53 AM
marketbeat.com logoJPMorgan Chase & Co. Reduces Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
marketbeat.com - June 11 at 4:18 AM
morningstar.com logoPMV Pharmaceuticals Inc Ordinary Shares
morningstar.com - June 10 at 10:04 AM
marketbeat.com logoUBS Group AG Purchases 164,543 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
marketbeat.com - June 4 at 4:30 AM
marketbeat.com logo115,689 Shares in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Bought by Connor Clark & Lunn Investment Management Ltd.
marketbeat.com - June 1 at 6:51 AM
marketbeat.com logoCitigroup Inc. Has $1.01 Million Stock Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
marketbeat.com - May 31 at 5:21 AM
marketbeat.com logoHRT Financial LP Increases Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
marketbeat.com - May 30 at 6:25 AM
marketbeat.com logoPrincipal Financial Group Inc. Has $7.79 Million Stock Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
marketbeat.com - May 29 at 5:19 AM
markets.businessinsider.com logoThe Latest Analyst Ratings for PMV Pharma
markets.businessinsider.com - May 17 at 4:55 PM
msn.com logoHC Wainwright & Co. Reiterates PMV Pharmaceuticals (PMVP) Buy Recommendation
msn.com - May 17 at 11:55 AM
msn.com logoOppenheimer Reiterates PMV Pharmaceuticals (PMVP) Outperform Recommendation
msn.com - May 12 at 2:27 PM
marketwatch.com logo8-K: PMV Pharmaceuticals, Inc.
marketwatch.com - May 11 at 11:26 PM
finanznachrichten.de logoPMV Pharmaceuticals, Inc.: PMV Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Highlights
finanznachrichten.de - May 10 at 5:22 PM
finance.yahoo.com logoPMV Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Highlights
finance.yahoo.com - May 10 at 5:22 PM
msn.com logoWall Street’s 10 most shorted stocks right now, including Silvergate and WeWork
msn.com - March 27 at 10:53 AM
marketbeat.com logoAssenagon Asset Management S.A. Lowers Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
marketbeat.com - March 27 at 4:45 AM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for PMV Pharmaceuticals (PMVP)
markets.businessinsider.com - March 20 at 10:13 AM
marketbeat.com logoCitadel Advisors LLC Sells 521,780 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
marketbeat.com - March 13 at 5:10 AM
marketbeat.com logoResearch Analysts Set Expectations for PMV Pharmaceuticals, Inc.'s Q1 2023 Earnings (NASDAQ:PMVP)
marketbeat.com - March 6 at 1:34 AM
marketbeat.com logoTudor Investment Corp Et Al Acquires Shares of 85,553 PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
marketbeat.com - March 3 at 6:19 AM
marketbeat.com logoPDT Partners LLC Buys Shares of 18,863 PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)
marketbeat.com - March 2 at 5:59 AM
benzinga.com logoPMV Pharmaceuticals shares are trading lower after the company reported FY22 financial results.
benzinga.com - March 1 at 2:33 PM
finance.yahoo.com logoPMV Pharmaceuticals to Participate at Upcoming Investor Conferences in March
finance.yahoo.com - March 1 at 9:33 AM
Get PMV Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PMVP and its competitors with MarketBeat's FREE daily newsletter.



PMVP Media Mentions By Week

PMVP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PMVP
News Sentiment
▼
0.00

0.53
▲
Average
Medical
News Sentiment

PMVP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PMVP Articles
This Week
▼
0

1
▲
PMVP Articles
Average Week

Get PMV Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PMVP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:PMVP) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -